A. Ferzi

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

Marina Elena Cazzaniga, Laura Cortesi, A. Ferzi et al. · Breast Cancer Research and Treatment · 2016 · 60 citations · Full text

Medicine, Oncology, Pharmacology +14

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

Marina Elena Cazzaniga, G. Pinotti, Emilia Montagna et al. · The Breast · 2019 · 57 citations

Medicine, Oncology, Breast Oncology +9

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Raffaella Palumbo, Federico Sottotetti, Giuseppe Trifirò et al. · Drug Design Development and Therapy · 2015 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Stefania Gori, Filippo Montemurro, Simon Spazzapan et al. · Annals of Oncology · 2011 · 41 citations · Full text

Medicine, Oncology, Pharmacology +16

Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study

Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti et al. · Therapeutic Advances in Medical Oncology · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17